{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:54:39Z","timestamp":1789203279424,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.cca.2010.03.018","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T14:29:16Z","timestamp":1269613756000},"page":"965-971","source":"Crossref","is-referenced-by-count":26,"title":["Anti-PM\/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma"],"prefix":"10.1016","volume":"411","author":[{"given":"L.","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Blockmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Verschueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Westhovens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Op De Be\u00e9ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vermeersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.W.","family":"Burlingame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2010.03.018_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2010.03.018_bib2","first-page":"80","article-title":"The clinical relevance of autoantibodies in scleroderma","volume":"5","author":"Ho","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2010.03.018_bib3","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.autrev.2008.06.010","article-title":"Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies","volume":"7","author":"Koenig","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2010.03.018_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2010.03.018_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s001090050381","article-title":"Identification of an alpha-helical epitope region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides","volume":"78","author":"Bluthner","year":"2000","journal-title":"J Mol Med"},{"key":"10.1016\/j.cca.2010.03.018_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.autrev.2008.12.001","article-title":"PM1-alpha ELISA: the assay of choice for the detection of anti-PM\/Scl autoantibodies?","volume":"8","author":"Mahler","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2010.03.018_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.03.018_bib8","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.03.018_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","article-title":"Guidelines for the management of rheumatoid arthritis: 2002 update","volume":"46","author":"American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.03.018_bib10","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2010.03.018_bib11","first-page":"328","article-title":"Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients","volume":"16","author":"Alarc\u00f3n-Segovia","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2010.03.018_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"European Study Group on Classification Criteria for Sjogren's Syndrome: a revised version of the European criteria proposed by the American\u2013European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2010.03.018_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/clinchem\/45.2.311a","article-title":"Evaluation of a dot-blot method for identification of antibodies against extractable nuclear antigens and anti-cytoplasmic antibodies","volume":"45","author":"Mewis","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2010.03.018_bib14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature (Lond)"},{"key":"10.1016\/j.cca.2010.03.018_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1373\/clinchem.2008.115626","article-title":"Heterogeneous nuclear ribonucleoprotein H1, a novel nuclear autoantigen","volume":"55","author":"Van den Bergh","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2010.03.018_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/art.1780330508","article-title":"Immunogenetic associations of scleroderma-related antinuclear antibodies","volume":"33","author":"Genth","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.03.018_bib17","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.03.018_bib18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","article-title":"Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy","volume":"55","author":"Selva-O'callaghan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.03.018_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3899\/jrheum.090677","article-title":"Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study","volume":"37","author":"Meyer","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2010.03.018_bib20","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/ar2614","article-title":"Antibodies against PM\/Scl-5 and PM\/Scl-100 are independent markers for different subsets of systemic sclerosis patients","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2010.03.018_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.cca.2010.03.018_bib22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.autrev.2009.02.002","article-title":"Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression","volume":"8","author":"Cavazanna","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cca.2010.03.018_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/rheumatology\/37.1.15","article-title":"Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis","volume":"37","author":"Bunn","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.cca.2010.03.018_bib24","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/art.22043","article-title":"Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I\/III antibodies","volume":"54","author":"Yamasaki","year":"2006","journal-title":"Arthritis Rheum"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110002068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898110002068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T09:14:44Z","timestamp":1591175684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898110002068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":24,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0009898110002068"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2010.03.018","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}